XT
RMD icon

XTX Topco’s ResMed RMD Stock Holding History

XTX Topco’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,386
Closed -$6.15M – 4631
2026
Q1 		$6.15M Buy
+27,386
New +$6.82M 0.11% 197
2025
Q2 		– Sell
-1,583
Closed -$354K – 3037
2025
Q1 		$354K Sell
1,583
-283
-15% -$66.1K 0.02% 1282
2024
Q4 		$427K Buy
1,866
+631
+51% +$152K 0.04% 908
2024
Q3 		$301K Sell
1,235
-10,069
-89% -$2.25M 0.02% 1180
2024
Q2 		$2.16M Buy
11,304
+7,478
+195% +$1.52M 0.19% 109
2024
Q1 		$758K Buy
+3,826
New +$701K 0.1% 261
2023
Q1 		– Sell
-4,787
Closed -$996K – 1607
2022
Q4 		$996K Buy
+4,787
New +$1.05M 0.21% 88
2022
Q3 		– Sell
-1,695
Closed -$355K – 1345
2022
Q2 		$355K Buy
+1,695
New +$361K 0.15% 218
2021
Q3 		– Sell
-1,456
Closed -$359K – 1010
2021
Q2 		$359K Buy
+1,456
New +$306K 0.12% 288

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco's RMD Position: Q2 2026 in Review

XTX Topco sold out of ResMed (RMD) in Q2 2026, closing a stake of 27,386 shares — an estimated $6.15M sold.

XTX Topco first reported a position in RMD in Q2 2021 and held it in 9 quarters. The position peaked at $6.15M in Q1 2026. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • XTX Topco reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 27,386 ResMed shares in Q2 2026, an estimated $6.15M.
  • XTX Topco first reported a position in ResMed in Q2 2021 and held it in 9 quarters.
  • XTX Topco's ResMed position peaked at $6.15M in Q1 2026.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.